Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Radostina K. Manova

Radostina K. Manova

NVWA, Product Safety Authority, The Netherlands

Title: An application of HRMS QTOF in the routine analysis of veterinary drug residues

Biography

Biography: Radostina K. Manova

Abstract

The use of veterinary drugs in food-producing animals may pose a risk to public health. In order to protect the public and animal health, the EU legislation requires monitoring programs assuring that veterinary residues do not exceed maximum residue limits. For the implementation of such programs, the routine laboratories use targeted analysis for multi-residue determination with triple-quadrupole mass spectrometric detection (e.g. LC-MS/MS). Recently, the use of high-resolution mass (HRMS) analyzers has gained popularity for the screening of unlimited number of analytes in complex matrices. As a result, the HRMS analyzers are playing already a central role in routine pesticide residue analysis. However, the potential of HRMS methods in the analysis of veterinary drugs is not yet fully explored to the level of routine use. This presentation will discuss development and validation of a liquid chromatography–high resolution mass spectrometry (LC–HRMS) method for screening, identification and quantification of beta-agonists in biological matrices. The evaluation of data acquisition approach on hybrid quadropule-time-of-flight (QTOF) mass analyzer will be discussed: full-scan MS and a combination of full-scan and broadband CID experiments. The development of exact mass product ion spectra database and the selection of quantifier/qualifier ions for reliable identification will be described. The combination of highly selective HRMS method with a generic sample preparation will be evaluated for the targeted and non-targeted screening workflow. Finally, regulatory aspects concerning validation of HRMS methods will be also mentioned.